Le Lézard
Classified in: Health, Business
Subjects: SVY, ECO

Herbals & Naturals Seeing Increased Use Across Largest Consumer Health Markets Globally According to New Nicholas Hall Group Report


LONDON, September 19, 2018 /PRNewswire/ --

Consumers in some of the largest healthcare markets globally are increasingly turning to herbal & natural medicines and supplements, fuelling a huge boom in sales of Herbals & Naturals, according to a new report from The Nicholas Hall Group.

The new Herbals & Naturals report found that 9 markets (Australia, Brazil, Canada, China, Germany, India, Italy, Japan, USA) together added US$1,564mn in net sales in 2017, with China and USA the largest contributors. The combined Herbals & Naturals category in these markets totalled $33bn in 2017, growing by 5.0%, well ahead of growth of allopathic medicines at just 3.0%.

Some of the factors driving this growth include health & wellness climbing up the list of consumer priorities and herbal & natural options gaining prominence thanks to being suitable for children and perceived as safer than allopathic options. With medicated ingredients increasingly scrutinised and restricted, consumer concerns have risen about the safety of conventional medicines. Herbals & naturals have an increasing reputation for efficacy, with scientific studies / clinical backing enhancing the standing of many H&N brands.

Probiotics form the single fastest-growing category among Herbals & Naturals (averaging +11% a year since 2013), driven by rising awareness of benefits, consumer focus on prevention, expansion into new niches and increasing segmentation. Positioning of many probiotics has evolved beyond well-established gastrointestinal health and immunity benefits into multiple areas, including women's health, mother & baby, metabolic, stress, healthy ageing, etc. Options for children are proving particularly popular.

Other growth areas include herbal & natural cough remedies (averaging +8% growth a year) and topical analgesics (+7% a year). Herbal & natural cough is enjoying a surge in demand, helped by safety concerns over allopathic options and restrictions placed on certain ingredients (DXM, codeine); plenty of launch activity, with ivy extract, thyme and honey the key growth segments. Among pain gels & rubs, the efficacy of herbal & natural formulations is highlighted, many brands relying on trusted heritage, with celebrity endorsement critical in markets like Japan and USA. Menthol and camphor are common and popular ingredients, alongside methyl salicylate, comfrey, capsaicin and arnica. China is dominated by TCMs, India by ayurvedic remedies, while homeopathics are significant in Europe and USA.

The full report, Herbals & Naturals: Opportunities in a Vast & Dynamic Area of Consumer Health, is available now and more details can be found here: https://nicholashall.com/report/herbals-naturals

For more details contact [email protected], +44(0)1702-220-200


These press releases may also interest you

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...

at 16:27
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...



News published on and distributed by: